News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,418 Results
Type
Article (363)
Company Profile (4)
Press Release (16051)
Section
Business (8635)
Career Advice (10)
Deals (1199)
Drug Delivery (1)
Drug Development (1542)
Employer Resources (2)
FDA (233)
Job Trends (370)
News (10778)
Policy (456)
Tag
Academia (51)
Allergies (3)
Alliances (464)
ALS (6)
Alzheimer's disease (36)
Antibody-drug conjugate (ADC) (1)
Approvals (241)
Artificial intelligence (8)
Autoimmune disease (1)
Bankruptcy (3)
Best Places to Work (363)
Biosimilars (1)
Biotechnology (5)
Bladder cancer (1)
Breast cancer (7)
Cancer (82)
Cardiovascular disease (4)
Career advice (10)
CAR-T (3)
Cell therapy (12)
Cervical cancer (1)
Clinical research (1336)
Collaboration (11)
Compensation (6)
COVID-19 (101)
CRISPR (1)
C-suite (4)
Cystic fibrosis (2)
Data (162)
Depression (1)
Diabetes (10)
Diagnostics (230)
Digital health (2)
Drug discovery (9)
Drug pricing (5)
Duchenne muscular dystrophy (5)
Earnings (8451)
Employer resources (2)
Events (1548)
Executive appointments (3)
FDA (358)
Frontotemporal dementia (1)
Funding (15)
Gene editing (1)
Gene therapy (2)
GLP-1 (33)
Government (77)
Guidances (80)
Healthcare (638)
IgA nephropathy (2)
Immunology and inflammation (4)
Indications (1)
Infectious disease (106)
Inflammatory bowel disease (3)
Influenza (2)
Intellectual property (6)
IPO (1005)
IRA (2)
Job creations (23)
Job search strategy (9)
Labor market (1)
Layoffs (6)
Legal (36)
Lung cancer (11)
Lymphoma (14)
Manufacturing (3)
MASH (6)
Medical device (520)
Medtech (526)
Mergers & acquisitions (207)
Metabolic disorders (36)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (3)
Neuroscience (73)
NextGen: Class of 2025 (99)
Non-profit (64)
Now hiring (1)
Obesity (12)
Pancreatic cancer (5)
Parkinson's disease (6)
Patents (12)
Patient recruitment (5)
Peanut (1)
People (535)
Pharmacy benefit managers (1)
Phase I (355)
Phase II (557)
Phase III (569)
Pipeline (360)
Policy (2)
Postmarket research (39)
Preclinical (127)
Radiopharmaceuticals (6)
Rare diseases (11)
Real estate (31)
Recruiting (2)
Regulatory (409)
Reports (1)
Research institute (61)
Resumes & cover letters (1)
Rett syndrome (1)
RSV (1)
Schizophrenia (13)
Series A (6)
Series B (2)
Sickle cell disease (4)
Spinal muscular atrophy (2)
Startups (27)
Tariffs (2)
Vaccines (22)
Venture capital (3)
Weight loss (16)
Women's health (4)
Date
Last 7 days (20)
Last 30 days (57)
Last 365 days (1080)
2025 (1067)
2024 (1196)
2023 (1239)
2022 (1289)
2021 (4166)
2020 (1289)
2019 (895)
2018 (781)
2017 (609)
2016 (335)
2015 (607)
2014 (286)
2013 (213)
2012 (253)
2011 (311)
2010 (273)
Location
Africa (2)
Alabama (1)
Arizona (6)
Asia (921)
Australia (120)
California (322)
Canada (88)
China (16)
Colorado (20)
Connecticut (47)
Delaware (6)
Europe (1760)
Florida (100)
Georgia (13)
Idaho (1)
Illinois (25)
India (1)
Indiana (27)
Japan (6)
Kansas (1)
Kentucky (2)
Louisiana (5)
Maine (5)
Maryland (32)
Massachusetts (272)
Michigan (12)
Minnesota (25)
Missouri (8)
Montana (4)
Nevada (4)
New Hampshire (4)
New Jersey (100)
New York (77)
North Carolina (42)
Northern California (162)
Ohio (9)
Pennsylvania (125)
South America (26)
Southern California (127)
Texas (44)
United States (1360)
Utah (29)
Virginia (2)
Washington D.C. (2)
Washington State (18)
Wisconsin (4)
16,418 Results for "231".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course
To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 billion for the quarter while Zepbound in weight loss booked $2.31 billion.
May 1, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation
January 2, 2025
·
5 min read
Cerebrospinal Fluid (CSF) Management Market Is Expected To Reach USD 2.31 Billion in 2028
The global cerebrospinal fluid (CSF) management market size is expected to reach USD 2.31 Billion in 2028 and register a revenue CAGR of 4.8% over the forecast period, according to latest report by Reports and Data.
August 17, 2022
·
7 min read
MorphoSys AG Reports Non-Cash Impairment Charge of € 231 Million on Goodwill After Consolidation of Research and Discovery Functions; Corresponding Increase of Group Operating Expenses in 2021
MorphoSys AG announces that it will account for a non-cash impairment charge on goodwill in the amount of approximately € 231 million.
March 10, 2022
·
3 min read
Rapid Medical Diagnostic Kits Market to Top US$ 23.1 Bn by 2031 as Demand Grows amid Surging Burden of Infectious Diseases
Fact.MR – A Market Research and Competitive Intelligence Provider: As per a comprehensive survey by Fact.MR, the global rapid medical diagnostic kits market is projected to top US$ 23.1 Bn in 2031.
October 28, 2021
·
8 min read
Santhera Grants Exclusive North America License for Vamorolone to Catalyst Pharmaceuticals in Deal Valued at up to USD 231 Million Plus Royalties
Santhera Pharmaceuticals announces that it has signed an exclusive license and collaboration agreement for vamorolone in North America with Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on novel medicines for patients living with rare diseases.
June 20, 2023
·
10 min read
Drug Development
Cerevel Therapeutics Announces Positive Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients with Schizophrenia
Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced positive results from its Phase 1b clinical trial of CVL-231, a novel muscarinic M4-selective Positive Allosteric Modulator, in adult patients with schizophrenia.
June 29, 2021
·
13 min read
Genetown
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Phio Pharmaceuticals Corp. announced that the United States Patent and Trademark Office has granted patent application 17/150,614 for two of its INTASYL Compounds, RXI-185 and RXI-231.
March 6, 2024
·
4 min read
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Lexaria Bioscience Corp. announced that it has entered into definitive agreements for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 per share in a registered direct offering priced at-the-market under Nasdaq rules.
February 15, 2024
·
6 min read
Drug Development
Lexaria’s Submits Investigational New Drug Application
Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the “Company” or “Lexaria”) announces that, on January 29, it submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for its planned U.S. phase 1b hypertension clinical trial HYPER-H23-1 of DehydraTECH-CBD.
January 30, 2024
·
5 min read
1 of 1,642
Next
